v3.25.1
Loss Per Share
3 Months Ended
Mar. 31, 2025
Earnings Per Share [Abstract]  
Loss Per Share
12. Loss Per Share
Basic net loss per share attributable to Series A and Series B common stockholders is computed by dividing the net loss by the number of weighted-average outstanding common shares. Diluted net loss income per share attributable to Series A and Series B common stockholders is determined by giving effect to all potential common equivalents during the reporting period, unless including them yields an antidilutive result, and is calculated using the treasury stock method. The Company considers its warrants, Investment Option, RSUs, stock options, and ESPP shares as potential common equivalents, but excluded them from the computation of diluted earnings per share attributable to common stockholders in the period presented, as their effect was antidilutive for the three months ended March 31, 2025 and 2024.
The rights, including the liquidation and dividend rights, of the holders of Series A and Series B common stock are identical, except with respect to voting and conversion. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis to each series of common stock and the resulting basic and diluted net loss per share attributable to common stockholders are, therefore, the same for both Series A and Series B common stock on both an individual and combined basis.
The following table presents the calculation of basic and diluted net loss per share attributable to Series A and Series B common stockholders for the three months ended March 31, 2025 and 2024 (in thousands, except share and per share data):
Three Months Ended March 31,
20252024
Net loss per share attributable to Series A and Series B common stockholders, basic and diluted:
Numerator:
Net loss$(14,089)$(12,882)
Denominator:
Weighted-average shares, basic and diluted274,198,213 261,332,411
Net loss per share attributable to Series A and Series B common stockholders, basic and diluted$(0.05)$(0.05)

The following table summarizes the potential common shares excluded from the computation of diluted net loss per share (in thousands):
As of March 31,
20252024
Warrants outstanding3,443,822 4,821,350 
Investment Option15,743,174 15,743,174 
RSUs outstanding20,026,174 14,564,170 
Options outstanding24,242,288 28,016,783 
ESPP325,602 444,835 
Total63,781,060 63,590,312